
Aptevo Therapeutics Inc.
APVOHealthcare|Biotechnology|US
$1.24
-0.03 (-2.36%)
DCF Value
$5119.24
Tangible Book / Share
$5.05
Cash / Share
$8.19
Next Earnings Report
Apr 1, 2027
EPS est. -$3.14
Financing Filings (last 12 months)
6
Shelf registrations / offering prospectuses — latest Oct 30, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (1)
Oct 2027
Est. completion
P1Acute Myeloid Leukemia (AML)
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
NCT06634394n=39
Recent Press Releases
Aptevo to Showcase Multispecific Platform at SITC 2026 Annual Meeting
Oct 14, 2026 · Accesswire
Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development
Sep 24, 2026 · Accesswire
Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML
Sep 3, 2026 · Accesswire
Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results
Aug 14, 2026 · Accesswire
Aptevo Therapeutics Announces Closing of Existing Warrants Exercise and PIPE for $4.5 Million Gross Proceeds
Aug 13, 2026 · Accesswire
Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds
Aug 12, 2026 · Accesswire
SEC Filings (137)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Nov 2, 2026 | 8-K | Material event | DocumentIndex |
| Oct 30, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Oct 26, 2026 | 8-K | Material event | DocumentIndex |
| Oct 23, 2026 | 8-K | Material event | DocumentIndex |
| Oct 14, 2026 | 8-K | Material event | DocumentIndex |
| Sep 25, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Sep 24, 2026 | 8-K | Material event | DocumentIndex |
| Sep 23, 2026 | 8-K | Material event | DocumentIndex |
| Sep 3, 2026 | 424B4 | Offering prospectus | DocumentIndex |
| Sep 3, 2026 | 8-K | Material event | DocumentIndex |
| Sep 2, 2026 | EFFECT | DocumentIndex | |
| Aug 31, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 26, 2026 | D | DocumentIndex | |
| Aug 21, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 21, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Aug 21, 2026 | 8-K | Material event | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 14, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | 8-K | Material event | DocumentIndex |
| Jul 31, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jul 31, 2026 | ARS | Annual report to holders | DocumentIndex |
| Jul 27, 2026 | 8-K | Material event | DocumentIndex |
| Jul 24, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jun 30, 2026 | 8-K | Material event | DocumentIndex |
| Jun 22, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 27, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| May 6, 2026 | 8-K | Material event | DocumentIndex |
| Mar 26, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 26, 2026 | 8-K | Material event | DocumentIndex |
| Mar 11, 2026 | 8-K | Material event | DocumentIndex |
| Feb 19, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 3, 2026 | 8-K | Material event | DocumentIndex |
| Jan 30, 2026 | EFFECT | DocumentIndex | |
| Jan 30, 2026 | 424B4 | Offering prospectus | DocumentIndex |